- Home
- DXR vs ICMB Comparison
DXR vs ICMB Comparison
Compare DXR & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- ICMB
- Stock Information
- Founded
- DXR 1970
- ICMB 2012
- Country
- DXR United States
- ICMB United States
- Employees
- DXR N/A
- ICMB N/A
- Industry
- DXR Medical/Dental Instruments
- ICMB Finance: Consumer Services
- Sector
- DXR Health Care
- ICMB Finance
- Exchange
- DXR Nasdaq
- ICMB Nasdaq
- Market Cap
- DXR 36.4M
- ICMB 41.1M
- IPO Year
- DXR N/A
- ICMB N/A
- Fundamental
- Price
- DXR $9.25
- ICMB $2.75
- Analyst Decision
- DXR Strong Buy
- ICMB
- Analyst Count
- DXR 1
- ICMB 0
- Target Price
- DXR $25.00
- ICMB N/A
- AVG Volume (30 Days)
- DXR 2.8K
- ICMB 45.8K
- Earning Date
- DXR 01-01-0001
- ICMB 05-13-2025
- Dividend Yield
- DXR N/A
- ICMB 17.60%
- EPS Growth
- DXR 86.16
- ICMB N/A
- EPS
- DXR 0.11
- ICMB 0.82
- Revenue
- DXR $119,714.00
- ICMB $20,996,189.00
- Revenue This Year
- DXR N/A
- ICMB N/A
- Revenue Next Year
- DXR N/A
- ICMB N/A
- P/E Ratio
- DXR $81.69
- ICMB $3.31
- Revenue Growth
- DXR N/A
- ICMB N/A
- 52 Week Low
- DXR $6.55
- ICMB $2.46
- 52 Week High
- DXR $10.00
- ICMB $3.67
- Technical
- Relative Strength Index (RSI)
- DXR 73.43
- ICMB 43.95
- Support Level
- DXR $8.29
- ICMB $2.66
- Resistance Level
- DXR $8.13
- ICMB $2.82
- Average True Range (ATR)
- DXR 0.32
- ICMB 0.10
- MACD
- DXR 0.14
- ICMB -0.02
- Stochastic Oscillator
- DXR 100.00
- ICMB 20.45
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.